{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:16:39Z","timestamp":1794536199826,"version":"4.9.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":1096,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jpainsymman.2017.08.001","type":"journal-article","created":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T00:18:22Z","timestamp":1502324302000},"page":"798-805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Effect of Prophylactic Fentanyl Buccal Tablet on Episodic Exertional Dyspnea: A Pilot Double-Blind Randomized Controlled Trial"],"prefix":"10.1016","volume":"54","author":[{"given":"David","family":"Hui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Kilgore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Frisbee-Hume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjeong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diwakar D.","family":"Balachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Bruera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2017.08.001_bib1","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jpainsymman.2013.06.013","article-title":"Definition, categorization, and terminology of episodic breathlessness: consensus by an International Delphi Survey","volume":"47","author":"Simon","year":"2014","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/jpm.2008.0158","article-title":"Characteristics and correlates of dyspnea in patients with advanced cancer","volume":"12","author":"Reddy","year":"2009","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jpainsymman.2012.02.022","article-title":"Episodic breathlessness in patients with advanced disease: a systematic review","volume":"45","author":"Simon","year":"2013","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jpainsymman.2015.07.020","article-title":"Epidemiology and characteristics of episodic breathlessness in advanced cancer patients: an observational study","volume":"51","author":"Mercadante","year":"2016","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib5","series-title":"National Cancer Policy Board, Institute of Medicine and National Research Council. Improving palliative care for cancer. Institute of Medicine","year":"2001"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/NJH.0000000000000137","article-title":"Hospice and Palliative Nurses Association 2015-2018 research agenda","volume":"17","author":"Buck","year":"2015","journal-title":"J\u00a0Hosp Palliat Nurs"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib7","first-page":"CD011008","article-title":"Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness","volume":"3","author":"Barnes","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/1049909114552692","article-title":"Opioids, exertion, and dyspnea: a review of the evidence","volume":"33","author":"Johnson","year":"2016","journal-title":"Am J Hosp Palliat Care"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib9","first-page":"4","article-title":"Fentanyl for episodic dyspnoea in cancer patients","volume":"3","author":"Benitez-Rosario","year":"2014","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jpainsymman.2005.10.002","article-title":"Oral transmucosal fentanyl citrate in the management of dyspnea crises in cancer patients","volume":"30","author":"Benitez-Rosario","year":"2005","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib11","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.jpainsymman.2008.08.002","article-title":"Intranasal fentanyl for episodic breathlessness","volume":"36","author":"Sitte","year":"2008","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib12","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/jpm.2007.0161","article-title":"Oral transmucosal fentanyl citrate for dyspnea in terminally ill patients: an observational case series","volume":"11","author":"Gauna","year":"2008","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jpainsymman.2013.03.017","article-title":"Effects of prophylactic subcutaneous fentanyl on exercise-induced breakthrough dyspnea in cancer patients: a preliminary double-blind, randomized, controlled trial","volume":"47","author":"Hui","year":"2014","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib14","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jpainsymman.2011.05.007","article-title":"Inhaled fentanyl citrate improves exercise endurance during high-intensity constant work rate cycle exercise in chronic obstructive pulmonary disease","volume":"43","author":"Jensen","year":"2012","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib15","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1152\/japplphysiol.01091.2014","article-title":"Does nebulized fentanyl relieve dyspnea during exercise in healthy man?","volume":"118","author":"Kotrach","year":"2015","journal-title":"J\u00a0Appl Physiol (1985)"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib16","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jpainsymman.2016.05.013","article-title":"Impact of prophylactic fentanyl pectin nasal spray on exercise-induced episodic dyspnea in cancer patients: a double-blind, randomized controlled trial","volume":"52","author":"Hui","year":"2016","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2217\/14796694.3.4.375","article-title":"Fentanyl buccal tablet: faster rescue analgesia for breakthrough pain?","volume":"3","author":"Lecybyl","year":"2007","journal-title":"Future Oncol"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib18","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.clinthera.2006.05.016","volume":"28","author":"Darwish","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib19","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/01.ajp.0000210932.27945.4a","article-title":"A\u00a0randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer","volume":"22","author":"Portenoy","year":"2006","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib20","first-page":"327","article-title":"Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain","volume":"5","author":"Slatkin","year":"2007","journal-title":"J\u00a0Support Oncol"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jpainsymman.2016.05.023","article-title":"EffenDys-fentanyl buccal tablet for the relief of episodic breathlessness in patients with advanced cancer: a multicenter, open-label, randomized, morphine-controlled, crossover, phase II trial","volume":"52","author":"Simon","year":"2016","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib22","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1185\/03007995.2012.683112","article-title":"Dosing fentanyl buccal tablet for breakthrough cancer pain: dose titration versus proportional doses","volume":"28","author":"Mercadante","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib23","doi-asserted-by":"crossref","first-page":"906","DOI":"10.7326\/0003-4819-119-9-199311010-00007","article-title":"Subcutaneous morphine for dyspnea in cancer patients","volume":"119","author":"Bruera","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/0091270006297749","article-title":"Absolute and relative bioavailability of fentanyl buccal tablet and oral transmucosal fentanyl citrate","volume":"47","author":"Darwish","year":"2007","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/0269216307076398","article-title":"Which measurement scales should we use to measure breathlessness in palliative care? A systematic review","volume":"21","author":"Dorman","year":"2007","journal-title":"Palliat Med"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib26","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4037\/ajcc1998.7.3.200","article-title":"Validity of the numeric rating scale as a measure of dyspnea","volume":"7","author":"Gift","year":"1998","journal-title":"Am J Crit Care"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1089\/jpm.2012.0364","article-title":"Dyspnea in hospitalized advanced cancer patients: subjective and physiologic correlates","volume":"16","author":"Hui","year":"2013","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib29","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1002\/cncr.29437","article-title":"Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: a prospective study","volume":"121","author":"Hui","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1081\/COPD-200050655","article-title":"Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale","volume":"2","author":"Ries","year":"2005","journal-title":"COPD"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0304-3959(92)90053-E","article-title":"Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain","volume":"48","author":"Bruera","year":"1992","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib32","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0895-4356(96)00206-5","article-title":"Assessing the minimal important difference in symptoms: a comparison of two techniques","volume":"49","author":"Redelmeier","year":"1996","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib33","doi-asserted-by":"crossref","first-page":"622","DOI":"10.7326\/0003-4819-118-8-199304150-00009","article-title":"Measuring health-related quality of life","volume":"118","author":"Guyatt","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib34","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jpainsymman.2013.02.019","article-title":"Fentanyl for the relief of refractory breathlessness: a systematic review","volume":"46","author":"Simon","year":"2013","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib35","first-page":"58","article-title":"Breakthrough pain in cancer patients: the need for evidence","volume":"17","author":"Hui","year":"2010","journal-title":"Eur J Palliat Care"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1185\/030079906X162818","article-title":"Fentanyl buccal tablet (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized, placebo-controlled study","volume":"23","author":"Portenoy","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/jpm.2006.0151","article-title":"A\u00a0titration strategy is needed to manage breakthrough cancer pain effectively: observations from data pooled from three clinical trials","volume":"10","author":"Hagen","year":"2007","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib38","first-page":"2335","article-title":"The use of fentanyl buccal tablets for breakthrough pain by using doses proportional to opioid basal regimen in a home care setting","volume":"21","author":"Mercadante","year":"2013","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib39","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1185\/03007995.2013.826640","article-title":"The use of sublingual fentanyl for breakthrough pain by using doses proportional to opioid basal regimen","volume":"29","author":"Mercadante","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib40","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jpainsymman.2015.05.016","article-title":"Fentanyl buccal tablet vs. oral morphine in doses proportional to the basal opioid regimen for the management of breakthrough cancer pain: a randomized, crossover, comparison study","volume":"50","author":"Mercadante","year":"2015","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2017.08.001_bib41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jpainsymman.2016.01.010","article-title":"Fentanyl pectin nasal spray versus oral morphine in doses proportional to the basal opioid regimen for the management of breakthrough cancer pain: a comparative study","volume":"52","author":"Mercadante","year":"2016","journal-title":"J\u00a0Pain Symptom Manage"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392417303937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392417303937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:19:46Z","timestamp":1760131186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392417303937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0885392417303937"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2017.08.001","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Prophylactic Fentanyl Buccal Tablet on Episodic Exertional Dyspnea: A Pilot Double-Blind Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2017.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}